Search filters

List of works by Juan Macías

A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection

article

A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)

scientific article published on 10 July 2019

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

scientific article published on 12 December 2012

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

scientific article published on 16 October 2013

A review of current anti-HCV treatment regimens and possible future strategies

article

Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C.

scientific article published in August 2005

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

scientific article published on 01 October 2008

Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection

scientific article published on 8 January 2015

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients

scientific article published on 7 August 2017

Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV.

scientific article published on 14 October 2012

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

scientific article published on 19 February 2013

Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient

scientific article published in July 2003

CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients

scientific article published in March 2000

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

scientific article published on September 2017

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients

scientific article

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

scientific article published on 22 July 2010

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort

scientific article

Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.

scientific article published on 10 April 2013

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.

scientific article published in September 2007

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients

scientific article published in January 2011

Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users.

scientific article

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

scientific article published on 7 June 2021

Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection

scientific article

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

scientific article published on 25 November 2021

Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers.

scientific article

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

scientific article published on 6 March 2011

Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

article

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

scientific article published in March 2004

Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

scientific article published on 29 May 2013

Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.

scientific article published on 24 February 2014

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

scientific article published in October 2009

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

scientific article

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment

scientific article published on 6 October 2011

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

scientific article published on 13 October 2008

Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection.

scientific article

Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain.

scientific article published in May 2001

False-positive results of leishmanin skin test due to phenol-containing diluent

scientific article

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

scientific article published on October 2009

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

scientific article published on 24 January 2017

Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain

scientific article published on 01 March 1996

Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy

scientific article published in March 2004

Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection

article

Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment

scientific article published in August 2004

HAART and the liver: friend or foe?

scientific article published on March 2010

HCV epidemiology in high-risk groups and the risk of reinfection.

scientific article

HIV-1 progression in hepatitis-C-infected drug users

scientific article published on 01 April 2001

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

scientific article published on 29 June 2012

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

scientific article published on 31 May 2016

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

scientific article

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

scientific article

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.

scientific article published on 25 November 2011

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

scientific article published on 24 October 2008

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

scientific article published on 11 September 2012

Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals

scientific article published on 17 June 2017

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

scientific article published on August 2012

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

scientific article published on 23 July 2015

High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.

scientific article

High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients

scientific article published in November 1999

High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease

scientific article published on December 2014

High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack

scientific article published in July 2008

Host genetics.

scientific article

IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.

scientific article published on September 2015

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians

scientific article

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

scientific article published on 9 July 2015

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

scientific article published on 27 September 2011

Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals

scientific article published on September 2015

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

scientific article published on 28 January 2018

Impact of observer experience on the reproducibility of transient elastometry in HIV/HCV co-infected patients.

scientific article published on July 2009

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus

scientific article published on 23 October 2003

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients

scientific article published on August 2014

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.

scientific article published in December 2006

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

scientific article

Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

scientific article published on 26 December 2020

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection

scientific article

Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels

scientific article published in March 2003

Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease

scientific article published in March 1998

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

scientific article published on 6 February 2001

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

article

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients

scientific article published on 29 December 2008

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients

scientific article published in July 2006

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

scientific article published on 4 June 2018

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography

scientific article published on August 2013

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.

scientific article published in July 2010

Kala-azar in HIV infection: the tip of the iceberg?

scientific article

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy.

scientific article published on 19 January 2012

Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients.

scientific article published on August 2014

Leishmania infantum (Protozoa, kinetoplastida): transmission from infected patients to experimental animal under conditions that simulate needle-sharing

scientific article published on 01 January 2002

Leishmania spp infection in injecting drug users

scientific article published in September 2002

Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

article

Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published in August 2009

Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis.

scientific article published on 9 March 2012

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.

scientific article published in October 2013

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 6 June 2012

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients

scientific article published on 21 December 2016

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis

scientific article

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C

article

Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients

scientific article published on 7 September 2011

Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis

scientific article

Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patients.

scientific article published on 20 June 2011

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection

scientific article published on 7 December 2015

Low Levels of HIV-1 Plasma Viral Load in Patients Infected with HIV-1 Subtype B and Advanced Immunosuppression

article

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals

scientific article published on 3 February 2017

Low prevalence of occult HBV infection among HIV-infected patients in Southern Spain

scientific article published on 8 November 2011

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.

scientific article published on 20 March 2015

Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients.

scientific article published on January 1998

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients.

scientific article published in July 2011

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

scientific article published on 09 November 2006

Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood

scientific article published in December 2001

Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.

scientific article published in November 2010

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy

scientific article published on 9 November 2002

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

scientific article published in October 2009

Necrotizing granulomatous vasculitis in advanced HIV infection

scientific article published on 01 November 2003

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

scientific article

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

scientific article published on 7 June 2012

Non-Alcoholic Fatty Liver Disease in HIV Infection

scientific article

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.

scientific article published on 28 March 2013

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder

scientific article published on 24 December 2018

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

scientific article published on 23 August 2005

Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.

scientific article published on October 2010

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

scientific article published on 13 December 2011

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

scientific article published in June 2014

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients

scientific article published in October 2010

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

scientific article published on January 2010

Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

scientific article

Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus- co-infected patients: still a role for liver biopsy?

scientific article published in August 2004

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

scientific article published on 30 August 2019

Prevalence of serum antibodies against Bartonella ssp. in a health population from the south area of the Seville province

scientific article

Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.

scientific article

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.

scientific article published on 7 December 2015

Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine

scientific article published on 01 October 1999

Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment

scientific article

Reduction of Immune System Activation in HIV-1-Infected Patients Undergoing Highly Active Antiretroviral Therapy

article

Regression of Invasive AIDS‐Related Kaposi's Sarcoma Following Antiretroviral Therapy

article

Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients

scientific article published in September 2003

Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy

scientific article published in November 2005

Reply to: "Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes"

scientific article published on 11 October 2019

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

scientific article published on 08 March 2019

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis

scientific article published on 5 September 2012

Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection

scientific article published on 01 February 1997

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.

scientific article published on 14 August 2013

Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection

scientific article published in July 2013

Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy

scientific article published on 20 May 2020

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

scientific article published on 27 September 2018

Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1

scientific article published on 01 July 1996

Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy

article

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

scientific article published on 22 November 2013

Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients.

scientific article published on 28 February 2013

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

scientific article

The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum.

scientific article

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

scientific article published on 11 September 2007

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy

scientific article published on 12 January 2005

Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure

scientific article

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.

scientific article published on 17 March 2011

Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain

scientific article published on July 1997

Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients

scientific article (publication date: December 2006)

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice

scientific article published on 17 February 2010

Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts

article

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals

scientific article published on 10 January 2020

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.

scientific article published on November 2013

Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users

scientific article

Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

scientific article published on 27 January 2017

[Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection]

scientific article published on 01 June 1998

[Can we advance the diagnosis of the sustained virological response to 12 weeks after finishing HVC treatment?]

scientific article published on 22 December 2011

[Effect of highly active antiretroviral therapy on the clinical onset of AIDS defined by clinical episodes]

scientific article published on 01 May 2002

[Granulomatous pneumonitis: a clinical manifestation and atypical pathology of pneumocystosis in AIDS]

scientific article published on 01 December 1995

[Impact of medical approach on the presentation form of AIDS defined by clinical episodes]

scientific article published on 01 February 1998

[Kinetics of Bartonella spp. IgG antibodies in cat-scratch disease and in asymptomatic HIV-infected patients]

scientific article published on 01 April 2003

[Prevalence of Bartonella spp. seropositivity in human immunodeficiency virus-infected and non infected intravenous drug abusers]

scientific article published on 01 November 2002

[The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection]

scientific article published on 01 February 1999

Paulina is supported by:

About Paulina

Help